A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...

A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...

Novo Nordisk said on Monday it would halt its collaboration with U.S. telehealth company Hims & Hers Health over the ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.

Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...

People started on a low dose of Amgen's long-acting experimental obesity drug MariTide lost as much weight as those given ...

Amanda Bynes is starting a weight loss journey and turning to Ozempic for help. In a video shared to her Instagram Stories on ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

Infection, delayed kidney function, kidney loss and death are all risks associated with kidney transplant surgery in obese ...